INNOVATE Corp. ( VATE ) Nowojorska Giełda Papierów Wartościowych

Cena: 5.39 ( 2.86% )

Aktualizacja 06-24 19:55
Nowojorska Giełda Papierów Wartościowych
Branża: Engineering & Construction
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Przemysł
Branża: Engineering & Construction
Zatrudnienie: 3 946
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 60%
Ilość akcji: 79 235 000
Debiut giełdowy: 2009-07-13
WWW: https://www.innovatecorp.com
CEO: Mr. Paul Kenneth Voigt
Adres: 295 Madison Avenue
Siedziba: 10017 New York
ISIN: US45784J1051
Opis firmy:

Innovate Corp., poprzez swoje spółki zależne, działa w dziedzinie infrastruktury, nauk przyrodniczych i spektrum w Stanach Zjednoczonych. Zapewnia usługi budowlane przemysłowe, stali konstrukcyjne i konserwacji obiektów do wykorzystania w projektach budowlanych komercyjnych, przemysłowych i infrastrukturalnych, takich jak budynki i kompleksy biurowe, hotele i kasyna, centra kongresowe, areny sportowe i stadiony, centra handlowe, szpitale, tamy, mosty, mosty, miny, metal, refinerie, młynki i papiery. Firma produkuje również kratownice i dźwigary; oraz produkuje i wyprostowuje rurę wodną, ​​zbiorniki do przechowywania wody, wkładki tunelowe, naczynia ciśnieniowe, sitki, filtry, separatory i inne spersonalizowane produkty. Ponadto oferuje zintegrowane rozwiązania inżynierii cyfrowej, modelowania i detali, budowy, instalacji sprzętu ciężkiego i usług obiektów; oraz detale stalowe i zbrojeniowe oraz usługi modelowania i zarządzania BIM, a także sprzęt używany w przemyśle ropy, gazu, petrochemicznym i rurociągów. Ponadto firma opracowuje produkty na wczesne zapalenie kości i stawów kolan oraz technologie estetyczne i medyczne dla skóry. Ponadto obsługuje stacje nadawcze na terenie i Azteca America, hiszpańskojęzyczna sieć nadawcza. Firma była wcześniej znana jako HC2 Holdings, Inc. i zmieniła nazwę na Innovate Corp. we wrześniu 2021 r. Firma została zarejestrowana w 1994 roku i ma siedzibę w Nowym Jorku w Nowym Jorku.

Wskaźniki finansowe
Kapitalizacja (USD) 71 596 448
Aktywa: 897 200 000
Cena: 5.39
Wskaźnik Altman Z-Score: 0.7
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -1.9
Ilość akcji w obrocie: 60%
Średni wolumen: 38 614
Ilość akcji 13 283 200
Wskaźniki finansowe
Przychody TTM 1 231 500 000
Zobowiązania: 1 038 300 000
Przedział 52 tyg.: 3.25 - 13.79
Piotroski F-Score: 4
Umiarkowany (średnia jakość finansowa)
EPS: -2.8
P/E branży: 14.7
Beta: 2.073
Raport okresowy: 2025-08-05
WWW: https://www.innovatecorp.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Paul Kenneth Voigt Interim Chief Executive Officer 481 486 1959
Mr. Michael J. Sena Chief Financial Officer & Corporate Secretary 1 077 900 1973
Anthony Rozmus Investor Relations Officer 0 0
Wiadomości dla INNOVATE Corp.
Tytuł Treść Źródło Aktualizacja Link
INNOVATE Corp. (VATE) Q1 2025 Earnings Call Transcript INNOVATE Corp. (NYSE:VATE ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Anthony Rozmus - Investor Relations Paul Voigt - Interim Chief Executive Officer Mike Sena - Chief Financial Officer Conference Call Participants Operator Good afternoon. And welcome to INNOVATE's First Quarter 2025 Earnings Conference Call. seekingalpha.com 2025-05-07 01:02:06 Czytaj oryginał (ang.)
INNOVATE Corp. Announces First Quarter 2025 Results - Infrastructure: DBM Global first quarter revenue of $264.9 million - - Life Sciences: MediBeacon ® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function - - Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - globenewswire.com 2025-05-06 20:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. to Report First Quarter 2025 Results on May 6th NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. globenewswire.com 2025-04-16 20:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. (VATE) Q4 2024 Earnings Call Transcript INNOVATE Corp. (NYSE:VATE ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Neel Sikka - Investor Relations Paul Voigt - Interim Chief Executive Officer Mike Sena - Chief Financial Officer Conference Call Participants Brian Charles - R.W. Pressprich Operator Good afternoon and welcome to INNOVATE Corp's Fourth Quarter and Full Year 2024 Earnings Conference Call. seekingalpha.com 2025-04-01 02:46:01 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results - Infrastructure: DBM Global fourth quarter revenue of $225.7 million - - Life Sciences: MediBeacon ® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function - - Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - globenewswire.com 2025-03-31 20:04:00 Czytaj oryginał (ang.)
INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. globenewswire.com 2025-02-27 18:02:00 Czytaj oryginał (ang.)
MediBeacon® Transdermal GFR System receives device approval in China Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in February published MediBeacon study results on measured GFR (mGFR) using relmapirazin versus estimated GFR (eGFR) for the purpose of classifying patient Chronic Kidney Disease (CKD) stages. globenewswire.com 2025-02-25 11:00:00 Czytaj oryginał (ang.)
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function. globenewswire.com 2025-01-17 20:18:00 Czytaj oryginał (ang.)
INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has achieved several impressive milestones during 2024. The growing momentum of the brand coupled with recent key partnerships has positioned the company for substantial growth across the aesthetics and wellness sectors. globenewswire.com 2024-11-20 10:22:00 Czytaj oryginał (ang.)
INNOVATE Corp. (VATE) Q3 2024 Earnings Call Transcript INNOVATE Corp. (VATE) Q3 2024 Earnings Call Transcript seekingalpha.com 2024-11-07 00:19:31 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Third Quarter 2024 Results - Infrastructure: DBM Global third quarter revenue of $232.8 million - - Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter - - Spectrum: Broadcasting's delivered another quarter of strong growth driven by network launches - globenewswire.com 2024-11-06 18:03:00 Czytaj oryginał (ang.)
INNOVATE Corp. to Report Third Quarter 2024 Results on November 6th NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. globenewswire.com 2024-10-16 20:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has received a letter from the New York Stock Exchange (“NYSE”) dated August 27, 2024 (the “Compliance Notice”), notifying the Company that it is no longer considered below the NYSE's continued listing criterion of a minimum average share price of US $1.00 over a 30 trading-day period (the "NYSE Minimum Price Requirement"). globenewswire.com 2024-09-03 20:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Second Quarter 2024 Results - Infrastructure: DBM Global achieved second quarter revenue of $305.2 million - - Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter - - Spectrum: Broadcasting's growth driven by launch of new networks and cost-cutting efforts - globenewswire.com 2024-08-07 20:04:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Extension of Effective Date for Reverse Stock Split to August 8, 2024 NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that the Company is amending the effective date for its 1-for-10 reverse stock split of the Company's common stock, par value $0.001 per share (the “Common Stock”). The reverse stock split will become effective at 5:00 p.m. Eastern Time on August 8, 2024, after close of trading on the New York Stock Exchange. Previously, the Company planned for the reverse stock split to become effective on August 2, 2024. The Company's Common Stock is expected to begin trading on a split-adjusted basis when the markets open on August 9, 2024, under the existing trading symbol “VATE”. globenewswire.com 2024-07-29 12:30:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces 1-for-10 Reverse Stock Split of the Company's Common Stock NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, par value $0.001 per share (the “Common Stock”). The reverse stock split will become effective at 5:00 p.m. Eastern Time on August 2, 2024, after close of trading on the New York Stock Exchange (“NYSE”). The Company's Common Stock is expected to commence trading on a split-adjusted basis when the markets open on August 5, 2024, under the existing trading symbol “VATE.” globenewswire.com 2024-07-19 13:10:00 Czytaj oryginał (ang.)
INNOVATE Corp. to Report Second Quarter 2024 Results on August 7th NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2024 on Wednesday, August 7, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. globenewswire.com 2024-07-17 20:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. (VATE) Q1 2024 Earnings Call Transcript INNOVATE Corp. (NYSE:VATE ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Paul Voigt – Interim Chief Executive Officer Mike Sena – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to INNOVATE Corp.'s First Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. seekingalpha.com 2024-05-08 02:12:08 Czytaj oryginał (ang.)
INNOVATE Corp. Announces First Quarter 2024 Results - Infrastructure: DBM Global achieved first quarter revenue of $307.9 million - - Life Sciences: R2 delivered record North America system sales in the first quarter 2024 - - Spectrum: Broadcasting's revenue growth driven by launch of new networks - globenewswire.com 2024-05-07 20:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. to Report First Quarter 2024 Results on May 7th NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2024 on Tuesday, May 7, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. globenewswire.com 2024-04-26 13:05:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Closing of Rights Offering NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today the closing of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024. Pursuant to the terms of the rights offering, 5.2 million shares of common stock are being purchased pursuant to the exercise of basic subscription rights and 0.1 million additional shares of common stock are being purchased under the over-subscription privilege. globenewswire.com 2024-04-24 20:47:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Preliminary Results of Rights Offering NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today the preliminary results of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024 (the “expiration date”). According to Computershare Trust Company, N.A. (the “subscription agent”), as of the expiration date, 18.1 million basic subscription rights were exercised to purchase an aggregate of 5.2 million shares of common stock and 0.1 million additional shares of common stock were subscribed for under the over-subscription privilege, subject to proration. globenewswire.com 2024-04-22 12:01:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Further Extension of Rights Offering Subscription Period NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 19, 2024, in order to allow stockholders and noteholders who are entitled to participate in the rights offering (holders of record of the Company's common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and 2026 Convertible Notes as of 5:00 p.m. Eastern Time on March 6, 2024) additional time to participate. The rights offering was initially scheduled to expire at 5:00 p.m. Eastern Time on March 25, 2024 and the expiration date was previously extended until 5:00 p.m. Eastern Time on April 9, 2024. globenewswire.com 2024-04-09 20:18:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Extension of Rights Offering Subscription Period NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 9, 2024, in order to allow stockholders and noteholders who are entitled to participate in the rights offering (holders of record of the Company's common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and 2026 Convertible Notes as of 5:00 p.m. Eastern Time on March 6, 2024) additional time to participate. globenewswire.com 2024-03-25 18:35:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Commencement of Rights Offering NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that it has commenced its previously announced $19.0 million rights offering for its common stock. globenewswire.com 2024-03-08 11:00:00 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Rights Offering Pricing NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that it has approved the pricing for its previously announced rights offering. globenewswire.com 2024-03-06 10:00:00 Czytaj oryginał (ang.)
INNOVATE Corp. (VATE) Q4 2023 Earnings Call Transcript INNOVATE Corp. (NYSE:VATE ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Anthony Rozmus - Investor Relations Paul Voigt - Interim Chief Executive Officer Mike Sena - Chief Financial Officer Operator Good afternoon, and welcome to INNOVATE Corp.'s Fourth Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. seekingalpha.com 2024-03-04 20:10:24 Czytaj oryginał (ang.)
INNOVATE Corp. Announces Fourth Quarter and Full Year 2023 Results - Infrastructure: DBM Global achieved fourth quarter revenue of $353.8 million - - Life Sciences: R2 experienced strong North America unit sales in the fourth quarter - - Spectrum: B roadcasting entered into agreements with PBS stations for new commercial opportunities with ATSC 3.0 - globenewswire.com 2024-03-04 18:05:00 Czytaj oryginał (ang.)